Diabetes cell therapies take evasive action
Elie Dolgin • February 25, 2022
Protective encapsulating devices and gene-editing technologies could obviate the need for antirejection drugs in stem-cell-derived therapies for diabetes.
Continue reading at Nature Biotechnology.
The detailed scans could inspire robots and biomechanical designs.
But the rise of robots and AI may disrupt the sport’s ethos.